To Access the Effects of Mucositis in Adults With Dental Implants (implantitis)

Colgate-Palmolive

Status and phase

Completed

Phase 3

Conditions

Mucositis

Treatments

Drug: Triclosan and Fluoride

Drug: Fluoride

Study type

Interventional

Funder types

Industry

Identifiers

CRO-0107-PERIO-MUC-ITA-PC

Details and patient eligibility

About

Clinical research for the treatment of mucositis subjects who have dental implants for a minimum of one-year.

Enrollment

60 patients

Sex

All

Ages

30 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Male and female subjects, ages 30-70.
Availability for the six-month duration of the clinical research study.
Good general health.
Subjects who have lost teeth for periodontal disease reasons and who have been restored with implants.
Minimum of 5 remaining teeth and a minimum of 2 implants.
Initial evaluation of the gingival and peri-implant mucosal tissues by determining full mouth bleeding on probing.
Initial plaque evaluation by determining full mouth presence/absence of plaque.
Signed Informed Consent Form.

Exclusion criteria

Tumor(s) of the soft or hard tissues of the oral cavity.
Untreated periodontal disease (purulent exudate, tooth mobility, and/or extensive loss or periodontal attachment or alveolar bone).
Carious lesions requiring immediate restorative treatment.
Uncontrolled Diabetes
Use of antibiotics any time during the one month prior to entry into the study.
Untreated peri-implantitis.
Participation in any other clinical research study or test panel within the three months prior to entry into the study.
Pregnant women or women who are breast feeding.
History of allergies to personal care/consumer products or their ingredients.
Medical condition which prohibits not eating/drinking for up to 2 hours.
Current alcohol or drug abuse.
Systemic or local disease conditions that would compromise post-operative healing.
Regular use of anti-inflammatory drugs.